Relmada Therapeutics, Inc. (FRA:4E2)

Relmada Therapeutics Statistics

Total Valuation

FRA:4E2 has a market cap or net worth of EUR 285.23 million. The enterprise value is 273.25 million.

Market Cap	285.23M
Enterprise Value	273.25M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	73.33M
Shares Outstanding	n/a
Shares Change (YoY)	+5.32%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.64%
Owned by Institutions (%)	17.43%
Float	65.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	35.35
P/TBV Ratio	35.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.71
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.86

Current Ratio	2.86
Quick Ratio	2.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -196.79% and return on invested capital (ROIC) is -126.65%.

Return on Equity (ROE)	-196.79%
Return on Assets (ROA)	-102.41%
Return on Invested Capital (ROIC)	-126.65%
Return on Capital Employed (ROCE)	-597.14%
Revenue Per Employee	n/a
Profits Per Employee	-2.82M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.26
200-Day Moving Average	0.94
Relative Strength Index (RSI)	63.96
Average Volume (20 Days)	9,317

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-49.30M
Pretax Income	-47.88M
Net Income	-47.88M
EBITDA	n/a
EBIT	-49.30M
Earnings Per Share (EPS)	-1.51

Balance Sheet

The company has 11.84 million in cash and n/a in debt, giving a net cash position of 11.84 million.

Cash & Cash Equivalents	11.84M
Total Debt	n/a
Net Cash	11.84M
Net Cash Per Share	n/a
Equity (Book Value)	8.07M
Book Value Per Share	0.24
Working Capital	8.24M

Cash Flow

Operating Cash Flow	-34.08M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:4E2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.32%
Shareholder Yield	-5.32%
Earnings Yield	-16.79%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1